Alexandra Drakaki

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

Powles, T., Valderrama, B. P., Gupta, S., Bedke, J., Kikuchi, E., Hoffman-Censits, J., Iyer, G., Vulsteke, C., Park, S. H., Shin, S. J., Castellano, D., Fornarini, G., Li, J-R., Gümüş, M., Mar, N., Loriot, Y., Fléchon, A., Duran, I., Drakaki, A., Narayanan, S., & 4 othersYu, X., Gorla, S., Moreno, B. H. & EV-302 Trial Investigators, 7 Mar 2024, In: New England journal of medicine. 390, 10, p. 875-888 14 p.

Research output: Contribution to journal › Article › Academic › peer-review